We reviewed tetracycline and erythromycin disk diffusion susceptibility of 457 isolates of BranhameUa catarrhalis. Four 
Our laboratory in Texas has performed disk diffusion susceptibility testing on respiratory isolates of Branhamella catarrhalis since 1982. The recovery in November and December of 1988 of three isolates of B. catarrhalis with small zones of inhibition to tetracycline by disk diffusion prompted us to review our susceptibility results with this drug, as well as with erythromycin. Identified within this study were the first isolates of B. catarrhalis resistant to tetracycline and erythromycin reported from the United States.
(A preliminary report of this work has been presented [C. W. Flanagan, L. C. Steele, R. J. Wallace, Jr., and D. R. Nash, Abstr. Annu. Meet. Am. Soc. Microbiol. 1988, A-33, p. 6].) B. catarrhalis isolates recovered from respiratory samples submitted to the clinical laboratory of the University of Texas Health Center were used for study. They were identified by standard methods (12) . ,-Lactamase testing was performed with nitrocefin disks (Cefinase; BBL Microbiology Systems, Cockeysville, Md.). Disk diffusion susceptibility testing was done at the time of isolation by using Mueller-Hinton agar and National Committee for Clinical Laboratory Standards guidelines (16) . Broth microdilution susceptibility testing was performed by using cation-supplemented Mueller-Hinton broth or Mueller-Hinton broth supplemented with 1% supplement B (Difco Laboratories, Detroit, Mich.). Repeat MICs were determined with selected strains at the Centers for Disease Control (Atlanta, Ga. (16) . Of the 457 isolates of B. catarrhalis, none fell in the resistant category and 16 (3.5%) had zones in the moderately susceptible category, of which 11 were recovered in 1987 and 1988. Two of these isolates were available for MIC determinations. For one the MIC was 0.25 ,ug/ml, and for the other the * Corresponding author. zone was 19 mm and MICs were 4 and 8 ,ug/ml when tested on two occasions in the Texas laboratory and >8 ,ug/ml when tested at the Centers for Disease Control. MICs for 106 random isolates with susceptible zones were all c0.5 ,ug/ml (Table 1) .
Of the 457 isolates tested with tetracycline, four isolates seen in 1987 and 1988 had zone sizes (11 to 12 mm) in the resistant category for tetracycline (<14 mm) (16) . The MICs for the two isolates available for MIC determinations were 16 ,igIml. The remaining 453 isolates all had zone sizes within the susceptible range (.19 mm) (16) , and MICs for 108 random isolates were all c0.5 ,ug/ml ( Table 1) . MICs of multiple drugs for the three isolates resistant by MIC determinations are shown in Table 2 .
Of the five patients with isolates within the resistant category for tetracycline or erythromycin, all were adults with chronic lung disease. Two patients were taking the drug to which their isolate of B. catarrhalis was resistant at the time it was recovered (one erythromycin and one tetracycline), and both presented to the hospital with worsening symptoms of cough and sputum production despite the use of their antibiotic, demonstrating that the isolates were also clinically resistant.
Erythromycin resistance among isolates of B. catarrhalis was seen as early as 1983 (8, 9) . In that year, Kallings reported seven strains from Sweden for which MICs were 4 to >8 ,ig/ml, a resistance rate of 3%. In 1986 Maesen and Davies reported that 6% of isolates from The Netherlands were resistant to erythromycin by a disk diffusion method. Breakpoints used to define this resistance were not given (13) . In that same year Thornley et al. noted that 3 of 96 (3%) of B. catarrhalis isolates from New Zealand were also erythromycin resistant (20) . Numerous other studies from Japan, England, Europe, and the United States have failed to detect erythromycin resistance (1, 2, 6, 7, 10, 19).
The two tetracycline-resistant isolates of B. catarrhalis available for MIC determinations were resistant to tetracycline, were moderately susceptible to doxycycline, and were highly susceptible to minocycline. One study as early as 1983 in Sweden described isolates with this level of doxycycline MICs, but tetracycline was not studied (8, 9) . Numerous studies since that time from the United States, Europe, and New Zealand have failed to demonstrate tetracycline resistance, although a number of studies evaluated minocycline and doxycycline rather than the parent tetracycline compound (1, 2, 6, 7, 13, 19) . In 1988, however, two reports of ANTIMICROB. AGENTS CHEMOTHER. 1126, 1987) , although no antimicrobial resistance has been associated with these plasmids. Given the recent spread of the tetM resistance determinant to related Neisseria species (11, 15, 18) , it appears to be a logical candidate to explain tetracycline resistance in B. catarrhalis. However, given the previous failures to identify recognized antibiotic-resistant determinants in B. catarrhalis and the unique nature of their P-lactamases (BRO enzymes), it seems more likely that the resistance determinants for tetracycline and erythromycin may also be different from currently recognized genes.
In a recent review of antimicrobial susceptibility testing, Doern and Jones suggested that routine susceptibility testing of B. catarrhalis may not be necessary (5) . The current study 
